OTCMKTS:CMLFU

CM Life Sciences Competitors

$16.58
-0.87 (-4.99 %)
(As of 04/9/2021 12:00 AM ET)
Add
Compare
Today's Range
$16.49
Now: $16.58
$17.25
50-Day Range
$15.36
MA: $19.39
$27.42
52-Week Range
$10.00
Now: $16.58
$30.80
Volume42,682 shs
Average Volume147,166 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Competitors

CM Life Sciences (OTCMKTS:CMLFU) Vs. SCCB, ACEVU, ACKIU, ADRAU, ADEXU, and IMPXU

Should you be buying CMLFU stock or one of its competitors? Companies in the industry of "--" are considered alternatives and competitors to CM Life Sciences, including 378 (SCCB), ACE Convergence Acquisition (ACEVU), Ackrell SPAC Partners I (ACKIU), Adara Acquisition (ADRAU), Adit EdTech Acquisition (ADEXU), and AEA-Bridges Impact (IMPXU).

378 (OTCMKTS:SCCB) and CM Life Sciences (OTCMKTS:CMLFU) are both -- companies, but which is the better business? We will compare the two companies based on the strength of their risk, valuation, institutional ownership, earnings, analyst recommendations, dividends and profitability.

Profitability

This table compares 378 and CM Life Sciences' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
378N/AN/AN/A
CM Life SciencesN/AN/AN/A

Valuation & Earnings

This table compares 378 and CM Life Sciences' revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
378N/AN/AN/AN/AN/A
CM Life SciencesN/AN/AN/AN/AN/A

Analyst Recommendations

This is a summary of current ratings and target prices for 378 and CM Life Sciences, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
3780000N/A
CM Life Sciences0000N/A

ACE Convergence Acquisition (OTCMKTS:ACEVU) and CM Life Sciences (OTCMKTS:CMLFU) are both -- companies, but which is the superior business? We will compare the two companies based on the strength of their risk, analyst recommendations, valuation, profitability, dividends, earnings and institutional ownership.

Analyst Ratings

This is a summary of recent recommendations and price targets for ACE Convergence Acquisition and CM Life Sciences, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
ACE Convergence Acquisition0000N/A
CM Life Sciences0000N/A

Profitability

This table compares ACE Convergence Acquisition and CM Life Sciences' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
ACE Convergence AcquisitionN/AN/AN/A
CM Life SciencesN/AN/AN/A

Valuation & Earnings

This table compares ACE Convergence Acquisition and CM Life Sciences' gross revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
ACE Convergence AcquisitionN/AN/AN/AN/AN/A
CM Life SciencesN/AN/AN/AN/AN/A

CM Life Sciences (OTCMKTS:CMLFU) and Ackrell SPAC Partners I (OTCMKTS:ACKIU) are both -- companies, but which is the better business? We will compare the two companies based on the strength of their earnings, risk, institutional ownership, profitability, valuation, analyst recommendations and dividends.

Analyst Recommendations

This is a breakdown of recent ratings for CM Life Sciences and Ackrell SPAC Partners I, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
CM Life Sciences0000N/A
Ackrell SPAC Partners I0000N/A

Profitability

This table compares CM Life Sciences and Ackrell SPAC Partners I's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
CM Life SciencesN/AN/AN/A
Ackrell SPAC Partners IN/AN/AN/A

Earnings and Valuation

This table compares CM Life Sciences and Ackrell SPAC Partners I's top-line revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
CM Life SciencesN/AN/AN/AN/AN/A
Ackrell SPAC Partners IN/AN/AN/AN/AN/A

Adara Acquisition (OTCMKTS:ADRAU) and CM Life Sciences (OTCMKTS:CMLFU) are both -- companies, but which is the superior business? We will compare the two businesses based on the strength of their earnings, valuation, profitability, analyst recommendations, institutional ownership, risk and dividends.

Valuation & Earnings

This table compares Adara Acquisition and CM Life Sciences' revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Adara AcquisitionN/AN/AN/AN/AN/A
CM Life SciencesN/AN/AN/AN/AN/A

Profitability

This table compares Adara Acquisition and CM Life Sciences' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Adara AcquisitionN/AN/AN/A
CM Life SciencesN/AN/AN/A

Analyst Recommendations

This is a summary of current recommendations for Adara Acquisition and CM Life Sciences, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Adara Acquisition0000N/A
CM Life Sciences0000N/A

Adit EdTech Acquisition (OTCMKTS:ADEXU) and CM Life Sciences (OTCMKTS:CMLFU) are both -- companies, but which is the better stock? We will contrast the two businesses based on the strength of their earnings, valuation, dividends, risk, profitability, analyst recommendations and institutional ownership.

Profitability

This table compares Adit EdTech Acquisition and CM Life Sciences' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Adit EdTech AcquisitionN/AN/AN/A
CM Life SciencesN/AN/AN/A

Analyst Recommendations

This is a summary of recent ratings and recommmendations for Adit EdTech Acquisition and CM Life Sciences, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Adit EdTech Acquisition0000N/A
CM Life Sciences0000N/A

Valuation & Earnings

This table compares Adit EdTech Acquisition and CM Life Sciences' gross revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Adit EdTech AcquisitionN/AN/AN/AN/AN/A
CM Life SciencesN/AN/AN/AN/AN/A

AEA-Bridges Impact (OTCMKTS:IMPXU) and CM Life Sciences (OTCMKTS:CMLFU) are both -- companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, analyst recommendations, earnings, valuation, profitability, risk and dividends.

Profitability

This table compares AEA-Bridges Impact and CM Life Sciences' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
AEA-Bridges ImpactN/AN/AN/A
CM Life SciencesN/AN/AN/A

Earnings and Valuation

This table compares AEA-Bridges Impact and CM Life Sciences' top-line revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
AEA-Bridges ImpactN/AN/AN/AN/AN/A
CM Life SciencesN/AN/AN/AN/AN/A

Analyst Ratings

This is a breakdown of current ratings and price targets for AEA-Bridges Impact and CM Life Sciences, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
AEA-Bridges Impact0000N/A
CM Life Sciences0000N/A


CM Life Sciences Competitors List

Competitor NameCompetitor BTM RankCompetitor PriceCompetitor Price ChangeCompetitor Market CapCompetitor RevenueCompetitor P/E RatioCompetitor Indicator(s)
378 logo
SCCB
378
0.5$25.60-0.5%$0.00N/A0.00
ACEVU
ACE Convergence Acquisition
0.0$10.95-0.3%$0.00N/A0.00News Coverage
ACKIU
Ackrell SPAC Partners I
0.0$10.21-0.4%$0.00N/A0.00
ADRAU
Adara Acquisition
0.0$9.97-0.3%$0.00N/A0.00High Trading Volume
ADEXU
Adit EdTech Acquisition
0.0$9.99-0.0%$0.00N/A0.00High Trading Volume
IMPXU
AEA-Bridges Impact
0.0$10.55-1.1%$0.00N/A0.00High Trading Volume
ARBGU
Aequi Acquisition
0.0$10.16-0.1%$0.00N/A0.00
AFAQU
AF Acquisition Corp. Units
0.0$10.00-0.4%$0.00N/A0.00News Coverage
African Gold Acquisition logo
AGACU
African Gold Acquisition
0.0$9.99-0.0%$0.00N/A0.00High Trading Volume
Quiet Period Expiration
ATAQU
Altimar Acquisition Corp. III
0.0$10.12-0.6%$0.00N/A0.00High Trading Volume
Quiet Period Expiration
AGCUU
Altimeter Growth
0.0$14.62-1.7%$0.00N/A0.00
ANZUU
Anzu Special Acquisition Corp I Units
0.0$10.08-0.4%$0.00N/A0.00Quiet Period Expiration
ATSPU
Archimedes Tech SPAC Partners Co. Unit
0.0$9.95-0.2%$0.00N/A0.00
ACTCU
ArcLight Clean Transition
0.0$20.94-6.1%$0.00N/A0.00Gap Up
ARKIU
Ark Global Acquisition Corp. Unit
0.0$10.02-0.8%$0.00N/A0.00
ARRWU
Arrowroot Acquisition Corp. Unit
0.0$10.02-0.3%$0.00N/A0.00Quiet Period Expiration
SWETU
Athlon Acquisition
0.0$10.06-0.6%$0.00N/A0.00
ACICU
Atlas Crest Investment
0.0$10.81-1.3%$0.00N/A0.00High Trading Volume
News Coverage
AUUD
Auddia
0.0$3.05-0.0%$0.00N/A0.00News Coverage
AEACU
Authentic Equity Acquisition
0.0$10.15-0.4%$0.00N/A0.00
AVANU
Avanti Acquisition
0.0$10.69-0.0%$0.00N/A0.00High Trading Volume
BRPMU
B. Riley Principal 150 Merger
0.0$10.05-0.2%$0.00N/A0.00
BCYPU
Big Cypress Acquisition
0.0N/AN/A$0.00N/A0.00
BIOTU
Biotech Acquisition
0.0$10.06-0.6%$0.00N/A0.00
BGFPX
Blackstone / GSO Floating Rate Enhanced Income Fund
0.5N/AN/A$0.00N/A0.00High Trading Volume
BGFVX
Blackstone / GSO Floating Rate Enhanced Income Fund
0.5$25.11-0.1%$0.00N/A0.00High Trading Volume
BOACU
Bluescape Opportunities Acquisition
0.0$10.75-0.7%$0.00N/A0.00High Trading Volume
BREZU
Breeze Holdings Acquisition
0.0$10.62-2.4%$0.00N/A0.00
BSA
BrightSphere Investment Group
0.0N/AN/A$0.00N/A0.00News Coverage
BTAQU
Burgundy Technology Acquisition
0.0$10.59-1.5%$0.00N/A0.00
CAHCU
CA Healthcare Acquisition
0.0$10.43-0.4%$0.00N/A0.00
CNBTF
Cannara Biotech
0.5$0.14-14.3%$0.00N/A0.00
CTAQU
Carney Technology Acquisition Corp. II
0.0$10.06-0.9%$0.00N/A0.00
GLBLU
Cartesian Growth
0.0$9.98-0.1%$0.00N/A0.00Quiet Period Expiration
CBAHU
CBRE Acquisition
0.0$10.25-0.4%$0.00N/A0.00High Trading Volume
CENHU
Centricus Acquisition
0.0$10.04-0.6%$0.00N/A0.00
CFVIU
CF Acquisition Corp. VI
0.0$10.00-0.1%$0.00N/A0.00
CLRMU
Clarim Acquisition
0.0$10.03-0.4%$0.00N/A0.00
CLIMU
Climate Real Impact Solutions II Acquisition
0.0$10.35-0.7%$0.00N/A0.00High Trading Volume
News Coverage
CMIIU
CM Life Sciences II
0.0$12.98-0.5%$0.00N/A0.00Quiet Period Expiration
CMLTU
CM Life Sciences III Inc. Unit
0.0$11.20-0.4%$0.00N/A0.00
COLIU
Colicity
0.0$10.21-0.1%$0.00N/A0.00Quiet Period Expiration
CLAAU
Colonnade Acquisition Corp. II
0.0$9.96-0.2%$0.00N/A0.00High Trading Volume
CHFWU
Consonance-HFW Acquisition
0.0$10.38-0.0%$0.00N/A0.00High Trading Volume
CONXU
CONX
0.0$10.35-0.6%$0.00N/A0.00
CRZNU
Corazon Capital V838 Monoceros
0.0$10.01-0.1%$0.00N/A0.00High Trading Volume
COVAU
COVA Acquisition
0.0$10.03-0.3%$0.00N/A0.00
CPTKU
Crown PropTech Acquisitions
0.0$10.00-0.2%$0.00N/A0.00High Trading Volume
DCRNU
Decarbonization Plus Acquisition Co. II
0.0$10.31-0.4%$0.00N/A0.00
DCRCU
Decarbonization Plus Acquisition Corp III
0.0$10.08-0.2%$0.00N/A0.00
This page was last updated on 4/11/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.